Related references
Note: Only part of the references are listed.ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare
Weijie Zhao et al.
LUNG CANCER (2016)
The Precision Medicine Initiative A New National Effort
Euan A. Ashley
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Single molecule and single cell epigenomics
Byung-Ryool Hyun et al.
METHODS (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Personalized genomic analyses for cancer mutation discovery and interpretation
Sian Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability
Matthias Scheffler et al.
ONCOTARGET (2015)
Knowledge Discovery and interactive Data Mining in Bioinformatics - State-of-the-Art, future challenges and research directions
Andreas Holzinger et al.
BMC BIOINFORMATICS (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
When Tissue Antigens and Antibodies Get Along: Revisiting the Technical Aspects of Immunohistochemistry-The Red, Brown, and Blue Technique
J. A. Ramos-Vara et al.
VETERINARY PATHOLOGY (2014)
Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer Cells
Christiaan F. Labuschagne et al.
CELL REPORTS (2014)
Targeting MET Amplification as a New Oncogenic Driver
Hisato Kawakami et al.
CANCERS (2014)
Principles and methods of integrative genomic analyses in cancer
Vessela N. Kristensen et al.
NATURE REVIEWS CANCER (2014)
A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis
Brett Delahunt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non-Small Cell Lung Cancer The 2004 World Health Organization Classification and Therapeutically Relevant Subsets
Juneko E. Grilley-Olson et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
Daniel F. Hayes
BMC MEDICINE (2013)
RET fusion gene: Translation to personalized lung cancer therapy
Takashi Kohno et al.
CANCER SCIENCE (2013)
Personalized Cancer Medicine: Molecular Diagnostics, Predictive Biomarkers, and Drug Resistance
D. Gonzalez de Castro et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Transcriptional data: a new gateway to drug repositioning?
Francesco Iorio et al.
DRUG DISCOVERY TODAY (2013)
A new genome-driven integrated classification of breast cancer and its implications
Sarah-Jane Dawson et al.
EMBO JOURNAL (2013)
Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets
Alessandro Gronchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
Juan Sandoval et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Criteria for the use of omics-based predictors in clinical trials
Lisa M. McShane et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HMDB 3.0-The Human Metabolome Database in 2013
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2013)
Prioritization of Cancer Marker Candidates Based on the Immunohistochemistry Staining Images Deposited in the Human Protein Atlas
Su-Chien Chiang et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer
Bin Liu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review
Agnieszka Smolinska et al.
ANALYTICA CHIMICA ACTA (2012)
Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
Rui Chen et al.
CELL (2012)
Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis
Wuwen Lv et al.
CLINICAL BIOCHEMISTRY (2012)
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Toshinori Hinoue et al.
GENOME RESEARCH (2012)
Translating cancer 'omics' to improved outcomes
Emily A. Vucic et al.
GENOME RESEARCH (2012)
Genetic Changes in Squamous Cell Lung Cancer A Review
Rebecca S. Heist et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Chipping away at the lung cancer genome
William Pao et al.
NATURE MEDICINE (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Personalized cancer medicine and the future of pathology
H. Moch et al.
VIRCHOWS ARCHIV (2012)
Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges
Purvesh Khatri et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples
Serban Nacu et al.
BMC MEDICAL GENOMICS (2011)
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Mary L. Disis
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
Felicitas Thol et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
Junko Tanizaki et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
Nicholas B. La Thangue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
RNA sequencing: advances, challenges and opportunities
Fatih Ozsolak et al.
NATURE REVIEWS GENETICS (2011)
Bioinformatics tools for cancer metabolomics
Grigoriy Blekherman et al.
METABOLOMICS (2011)
International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data
Junjun Zhang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
Integrative analysis of the melanoma transcriptome
Michael F. Berger et al.
GENOME RESEARCH (2010)
Towards proteome standards: The use of absolute quantitation in high-throughput biomarker discovery
Tzu-Chiao Chao et al.
JOURNAL OF PROTEOMICS (2010)
The Current State of Chromatin Immunoprecipitation
Philippe Collas
MOLECULAR BIOTECHNOLOGY (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Visualization of omics data for systems biology
Nils Gehlenborg et al.
NATURE METHODS (2010)
Gene-expression-based prognostic assays for breast cancer
Chungyeul Kim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Bayesian approach to transforming public gene expression repositories into disease diagnosis databases
Haiyan Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer
Rod K. Nibbe et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
Donal J. Brennan et al.
NATURE REVIEWS CANCER (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Potential of Human Saliva for Nuclear Magnetic Resonance-Based Metabolomics and for Health-Related Biomarker Identification
Hanne Christine Bertram et al.
ANALYTICAL CHEMISTRY (2009)
Epigenetic Changes in Cancer
Christine A. Iacobuzio-Donahue
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)
Eric Chun Yong Chan et al.
JOURNAL OF PROTEOME RESEARCH (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
ChIP-seq: advantages and challenges of a maturing technology
Peter J. Park
NATURE REVIEWS GENETICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
John C. Marioni et al.
GENOME RESEARCH (2008)
Predictive data mining in clinical medicine: Current issues and guidelines
Riccardo Bellazzi et al.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2008)
Translating insights from the cancer genome into clinical practice
Lynda Chin et al.
NATURE (2008)
Reverse-phase protein lysate microarrays for cell signaling analysis
Brett Spurrier et al.
NATURE PROTOCOLS (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Metabolomics: Available results, current research projects in breast cancer, and future applications
Wederson Marcos Claudino et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mapping of transcription factor binding regions in mammalian cells by ChIP: Comparison of array- and sequencing-based technologies
Ghia M. Euskirchen et al.
GENOME RESEARCH (2007)
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer
Alejandro Vaquez-martin et al.
EUROPEAN JOURNAL OF CANCER (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
Olaf Beckonert et al.
NATURE PROTOCOLS (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
Current concepts - Microarray analysis and tumor classification
John Quackenbush
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Review - Mass spectrometry and protein analysis
B Domon et al.
SCIENCE (2006)
Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study
A Stang et al.
LUNG CANCER (2006)
Machine learning in bioinformatics
Pedro Larranaga et al.
BRIEFINGS IN BIOINFORMATICS (2006)
Metabolomics technology and bioinformatics
Vladimir Shulaev
BRIEFINGS IN BIOINFORMATICS (2006)
Metabolomics reviewed: A new Omics platform technology for systems biology and implications for natural products research
S Rochfort
JOURNAL OF NATURAL PRODUCTS (2005)
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review
S Singhal et al.
CLINICAL CANCER RESEARCH (2005)
Protein microarrays as tools for functional proteomics
J LaBaer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments
MJ Buck et al.
GENOMICS (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
Methods and applications of antibody microarrays in cancer research
BB Haab
PROTEOMICS (2003)
Share Paper
